UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 3
to
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
SOMANETICS CORPORATION
(Name of Subject Company)
SOMANETICS CORPORATION
(Name of Person Filing Statement)
Common Shares, par value $0.01 per share
(Title of Class of Securities)
834445405
(CUSIP Number of Class of Securities)
Bruce J. Barrett
President and Chief Executive Officer
2600 Troy Center Drive
Troy, MI 48084-4771
(248) 244-1400
(Name, address and telephone number of person authorized to receive
notices and communications on behalf of the persons filing statement)
With copies to:
Charles Nathan
Latham & Watkins LLP
885 Third Avenue
New York, NY 10022
(212) 906-1200
o |
|
Check the box if the filing relates solely to preliminary communications made before
the commencement of a tender offer. |
TABLE OF CONTENTS
This Amendment No. 3 to the Schedule 14D-9 (the Amendment) amends and supplements the Schedule
14D-9 filed with the Securities and Exchange Commission on June 25, 2010 (as amended from time to
time, the Schedule 14D-9) by Somanetics Corporation, a Michigan corporation (the Company). The
Schedule 14D-9 relates to the tender offer by Covidien DE Corp., a Delaware corporation (Sub) and
a wholly owned subsidiary of United States Surgical Corporation, a Delaware company (Parent) and
a wholly owned indirect subsidiary of Covidien plc, to purchase all of the outstanding common
shares, par value $0.01 per share, of the Company (collectively, the Shares) at a purchase price
of $25.00 per Share, net to the seller thereof in cash, without interest and less any required
withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase
for Cash, dated June 25, 2010 (the Offer to Purchase), and in the related Letter of Transmittal
(as amended and supplemented from time to time, the Letter of Transmittal). The Offer to
Purchase and Letter of Transmittal are filed as Exhibits (a)(1) and (a)(2) to the Schedule 14D-9,
respectively.
The information in the Schedule 14D-9 is incorporated into this Amendment by reference to all of
the applicable items in the Schedule 14D-9, except that such information is hereby amended and
supplemented to the extent specifically provided herein.
Item 8. Additional Information.
Item 8 (Additional Information) of the Schedule 14D-9 is hereby amended and supplemented by
inserting the following paragraph after the first paragraph on page 33 under the heading
Litigation:
On July 15, 2010, a plaintiff filed a purported shareholder class action complaint in the
United States District Court, Eastern District of Michigan. The complaint, captioned Maryellen
Farrelly v. Bruce Barrett, et al., names as defendants the members of the Company Board, the
Company, Parent and Sub. The plaintiff claims that members of the Company Board breached their
fiduciary duties to the Companys shareholders and have violated
Sections 14(d)(4) and 14(e) of the Exchange Act. Plaintiff further claims that the Company,
Parent and Sub have aided and abetted the purported breach of fiduciary duties. In support of the
plaintiffs claims, the complaint alleges that the proposed transaction between the Company, Parent
and Sub involves inadequate disclosure and inadequate consideration. The complaint seeks
injunctive relief and the awarding of attorneys and experts fees. The foregoing description of
the Maryellen Farrelly v. Bruce Barrett, et al. complaint is qualified in its entirety by reference
to the complaint, which is included as Exhibit (a)(12) to this Schedule 14D-9 and incorporated
herein by reference. The Company believes the plaintiffs allegations lack merit and will contest
them vigorously.
Item 9. Exhibits.
Item 9 (Exhibits) of the Schedule 14D-9 is hereby amended and supplemented by adding the
following exhibit thereto:
(a)(12)
Complaint captioned Maryellen Farrelly v. Bruce Barrett, et al. filed July 15, 2010 in the United States District Court, Eastern District of Michigan.